{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:50:37Z","timestamp":1789602637242,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/nchembio.1911","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T17:25:56Z","timestamp":1442251556000},"page":"855-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["Synergistic, collaterally sensitive \u03b2-lactam combinations suppress resistance in MRSA"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1594-0233","authenticated-orcid":false,"given":"Patrick R","family":"Gonzales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell W","family":"Pesesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1358-0994","authenticated-orcid":false,"given":"Renee","family":"Bouley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1554-6340","authenticated-orcid":false,"given":"Brent A","family":"Biddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Suckow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey-Ann D","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Mobashery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayland","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,14]]},"reference":[{"key":"BFnchembio1911_CR1","doi-asserted-by":"crossref","unstructured":"Walsh, T.R., Weeks, J., Livermore, D.M. & Toleman, M.A. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. (2011).","DOI":"10.1016\/S1473-3099(11)70059-7"},{"key":"BFnchembio1911_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"J Davies","year":"2010","unstructured":"Davies, J. & Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417\u2013433 (2010).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"BFnchembio1911_CR3","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1007\/s00018-005-5148-6","volume":"62","author":"CCS Fuda","year":"2005","unstructured":"Fuda, C.C.S., Fisher, J.F. & Mobashery, S. \u03b2-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell. Mol. Life Sci. 62, 2617\u20132633 (2005).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnchembio1911_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers, H.F. & Deleo, F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629\u2013641 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnchembio1911_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.30.1.1","volume":"30","author":"F Malouin","year":"1986","unstructured":"Malouin, F. & Bryan, L.E. Modification of penicillin-binding proteins of \u03b2-lactam resistance. Antimicrob. Agents Chemother. 30, 1\u20135 (1986).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR6","doi-asserted-by":"publisher","first-page":"40802","DOI":"10.1074\/jbc.M403589200","volume":"279","author":"C Fuda","year":"2004","unstructured":"Fuda, C., Suvorov, M., Vakulenko, S.B. & Mobashery, S. The basis for resistance to \u03b2-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J. Biol. Chem. 279, 40802\u201340806 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1911_CR7","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/ja0434376","volume":"127","author":"C Fuda","year":"2005","unstructured":"Fuda, C. et al. Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall. J. Am. Chem. Soc. 127, 2056\u20132057 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1911_CR8","doi-asserted-by":"publisher","first-page":"16808","DOI":"10.1073\/pnas.1300118110","volume":"110","author":"LH Otero","year":"2013","unstructured":"Otero, L.H., Rojas-Altuve, A., Llarrull, L.I., Carrasco-L\u00f3pez, C. & Kumarasiri, M. How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proc. Natl. Acad. Sci. USA 110, 16808\u201316813 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1911_CR9","doi-asserted-by":"publisher","first-page":"9212","DOI":"10.1021\/ja8029448","volume":"130","author":"A Villegas-Estrada","year":"2008","unstructured":"Villegas-Estrada, A., Lee, M., Hesek, D., Vakulenko, S.B. & Mobashery, S. Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA \u03b2-lactam antibiotics. J. Am. Chem. Soc. 130, 9212\u20139213 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1911_CR10","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1128\/AAC.03622-14","volume":"58","author":"SW Long","year":"2014","unstructured":"Long, S.W. et al. PBP2a mutations causing high-level ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 58, 6668\u20136674 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jac\/dks354","volume":"68","author":"B Gu","year":"2013","unstructured":"Gu, B., Kelesidis, T., Tsiodras, S., Hindler, J. & Humphries, R.M. The emerging problem of linezolid-resistant Staphylococcus. J. Antimicrob. Chemother. 68, 4\u201311 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnchembio1911_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10096-010-1128-3","volume":"30","author":"SJ van Hal","year":"2011","unstructured":"van Hal, S.J., Paterson, D.L. & Gosbell, I.B. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-na\u00efve patient-a review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 30, 603\u2013610 (2011).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"BFnchembio1911_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMp0804651","volume":"360","author":"CA Arias","year":"2009","unstructured":"Arias, C.A. & Murray, B.E. Antibiotic-resistant bugs in the 21st century\u2014a clinical super-challenge. N. Engl. J. Med. 360, 439\u2013443 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnchembio1911_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ijantimicag.2005.05.005","volume":"26","author":"Y Bhusal","year":"2005","unstructured":"Bhusal, Y., Shiohira, C.M. & Yamane, N. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 26, 292\u2013297 (2005).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFnchembio1911_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7326\/0003-4819-139-6-200309160-00011","volume":"139","author":"M Sj\u00f6lund","year":"2003","unstructured":"Sj\u00f6lund, M., Wreiber, K., Andersson, D.I., Blaser, M. & Engstrand, L. Long-term persistence of resistant enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann. Intern. Med. 139, 483\u2013487 (2003).","journal-title":"Ann. Intern. Med."},{"key":"BFnchembio1911_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ijantimicag.2009.12.017","volume":"35","author":"A Tupin","year":"2010","unstructured":"Tupin, A. et al. Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. Int. J. Antimicrob. Agents 35, 519\u2013523 (2010).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFnchembio1911_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng.1038","volume":"44","author":"I Comas","year":"2012","unstructured":"Comas, I. et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 44, 106\u2013110 (2012).","journal-title":"Nat. Genet."},{"key":"BFnchembio1911_CR18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.1176667","volume":"325","author":"MA Fischbach","year":"2009","unstructured":"Fischbach, M.A. & Walsh, C.T. Antibiotics for emerging pathogens. Science 325, 1089\u20131093 (2009).","journal-title":"Science"},{"key":"BFnchembio1911_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","volume":"12","author":"GR Zimmermann","year":"2007","unstructured":"Zimmermann, G.R., Leh\u00e1r, J. & Keith, C.T. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today 12, 34\u201342 (2007).","journal-title":"Drug Discov. Today"},{"key":"BFnchembio1911_CR20","doi-asserted-by":"publisher","first-page":"13977","DOI":"10.1073\/pnas.0805965105","volume":"105","author":"M Hegreness","year":"2008","unstructured":"Hegreness, M., Shoresh, N., Damian, D., Hartl, D.L. & Kishony, R. Accelerated evolution of resistance in multidrug environments. Proc. Natl. Acad. Sci. USA 105, 13977\u201313981 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio1911_CR21","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/msb.2013.57","volume":"9","author":"V L\u00e1z\u00e1r","year":"2013","unstructured":"L\u00e1z\u00e1r, V. et al. Bacterial evolution of antibiotic hypersensitivity. Mol. Syst. Biol. 9, 700 (2013).","journal-title":"Mol. Syst. Biol."},{"key":"BFnchembio1911_CR22","doi-asserted-by":"publisher","first-page":"204ra132","DOI":"10.1126\/scitranslmed.3006609","volume":"5","author":"L Imamovic","year":"2013","unstructured":"Imamovic, L. & Sommer, M.O.A. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci. Transl. Med. 5, 204ra132 (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFnchembio1911_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher, H.W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1\u201312 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFnchembio1911_CR24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.ajic.2006.05.220","volume":"34","author":"LB Rice","year":"2006","unstructured":"Rice, L.B. Antimicrobial resistance in Gram-positive bacteria. Am. J. Infect. Control 34, S11\u2013S19 (2006).","journal-title":"Am. J. Infect. Control"},{"key":"BFnchembio1911_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev.bi.52.070183.004141","volume":"52","author":"DJ Waxman","year":"1983","unstructured":"Waxman, D.J. & Strominger, J.L. Penicillin-binding proteins and the mechanism of action of \u03b2-lactam antibiotics. Annu. Rev. Biochem. 52, 825\u2013869 (1983).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnchembio1911_CR26","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.chembiol.2011.08.015","volume":"18","author":"SH Lee","year":"2011","unstructured":"Lee, S.H. et al. Antagonism of chemical genetic interaction networks resensitize MRSA to \u03b2-lactam antibiotics. Chem. Biol. 18, 1379\u20131389 (2011).","journal-title":"Chem. Biol."},{"key":"BFnchembio1911_CR27","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1128\/AAC.01433-08","volume":"53","author":"T Koga","year":"2009","unstructured":"Koga, T. et al. Affinity of Tomopenem (CS-023) for penicillin-binding proteins in Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53, 1238\u20131241 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/jac\/35.1.75","volume":"35","author":"Y Yang","year":"1995","unstructured":"Yang, Y., Bhachech, N. & Bush, K. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by \u03b2-lactamases. J. Antimicrob. Chemother. 35, 75\u201384 (1995).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnchembio1911_CR29","doi-asserted-by":"publisher","first-page":"e86971","DOI":"10.1371\/journal.pone.0086971","volume":"9","author":"EM Campbell","year":"2014","unstructured":"Campbell, E.M. & Chao, L. A population model evaluating the consequences of the evolution of double-resistance and tradeoffs on the benefits of two-drug antibiotic treatments. PLoS ONE 9, e86971 (2014).","journal-title":"PLoS ONE"},{"key":"BFnchembio1911_CR30","doi-asserted-by":"publisher","first-page":"262ra156","DOI":"10.1126\/scitranslmed.3009940","volume":"6","author":"C Munck","year":"2014","unstructured":"Munck, C., Gumpert, H.K., Wallin, A.I.N., Wang, H.H. & Sommer, M.O.A. Prediction of resistance development against drug combinations by collateral responses to component drugs. Sci. Transl. Med. 6, 262ra156 (2014).","journal-title":"Sci. Transl. Med."},{"key":"BFnchembio1911_CR31","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0140-6736(00)04403-2","volume":"357","author":"M Kuroda","year":"2001","unstructured":"Kuroda, M. et al. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357, 1225\u20131240 (2001).","journal-title":"Lancet"},{"key":"BFnchembio1911_CR32","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1128\/AAC.00040-07","volume":"51","author":"F Goldstein","year":"2007","unstructured":"Goldstein, F. et al. Identification and phenotypic characterization of a \u03b2-lactam-dependent, methicillin-resistant Staphylococcus aureus strain. Antimicrob. Agents Chemother. 51, 2514\u20132522 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR33","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1128\/AAC.02621-12","volume":"57","author":"P Ar\u00eade","year":"2013","unstructured":"Ar\u00eade, P., Ministro, J. & Oliveira, D.C. Redefining the role of the \u03b2-lactamase locus in methicillin-resistant Staphylococcus aureus: \u03b2-lactamase regulators disrupt the MecI-mediated strong repression on mecA and optimize the phenotypic expression of resistance in strains with constitutive mecA. Antimicrob. Agents Chemother. 57, 3037\u20133045 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","volume":"41","author":"MC Berenbaum","year":"1989","unstructured":"Berenbaum, M.C. What is synergy? Pharmacol. Rev. 41, 93\u2013141 (1989).","journal-title":"Pharmacol. Rev."},{"key":"BFnchembio1911_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.prrv.2007.04.006","volume":"8","author":"L Saiman","year":"2007","unstructured":"Saiman, L. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'. Paediatr. Respir. Rev. 8, 249\u2013255 (2007).","journal-title":"Paediatr. Respir. Rev."},{"key":"BFnchembio1911_CR36","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing (document no. M100-S19) (CLSI, Wayne, Pennsylvania, 2009)."},{"key":"BFnchembio1911_CR37","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard (CLSI document M07-A8) (CLSI, Wayne, Pennsylvania, 2009)."},{"key":"BFnchembio1911_CR38","doi-asserted-by":"publisher","first-page":"9814","DOI":"10.1021\/ja5030657","volume":"136","author":"J Fishovitz","year":"2014","unstructured":"Fishovitz, J. et al. Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics. J. Am. Chem. Soc. 136, 9814\u20139817 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1911_CR39","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1128\/AAC.32.4.530","volume":"32","author":"P Somani","year":"1988","unstructured":"Somani, P., Freimer, E.H., Gross, M.L. & Higgins, J.T. Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis. Antimicrob. Agents Chemother. 32, 530\u2013534 (1988).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR40","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1128\/AAC.36.9.1997","volume":"36","author":"M Kinzig","year":"1992","unstructured":"Kinzig, M., Brismar, B. & Nord, C.E. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Antimicrob. Agents Chemother. 36, 1997\u20132004 (1992).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1128\/AAC.25.2.212","volume":"25","author":"HR Stutman","year":"1984","unstructured":"Stutman, H.R., Welch, D.F., Scribner, R.K. & Marks, M.I. In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Antimicrob. Agents Chemother. 25, 212\u2013215 (1984).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR42","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.chembiol.2011.08.015","volume":"18","author":"SH Lee","year":"2011","unstructured":"Lee, S.H. et al. Antagonism of chemical genetic interaction networks resensitize MRSA to \u03b2-lactam antibiotics. Chem. Biol. 18, 1379\u20131389 (2011).","journal-title":"Chem. Biol."},{"key":"BFnchembio1911_CR43","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1021\/jacs.5b00056","volume":"137","author":"R Bouley","year":"2015","unstructured":"Bouley, R. et al. Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one. J. Am. Chem. Soc. 137, 1738\u20131741 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnchembio1911_CR44","doi-asserted-by":"publisher","first-page":"e1003300","DOI":"10.1371\/journal.ppat.1003300","volume":"9","author":"P Ankomah","year":"2013","unstructured":"Ankomah, P., Johnson, P.J.T. & Levin, B.R. The pharmaco-, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations. PLoS Pathog. 9, e1003300 (2013).","journal-title":"PLoS Pathog."},{"key":"BFnchembio1911_CR45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/JB.109.1.262-265.1972","volume":"109","author":"SA Sonstein","year":"1972","unstructured":"Sonstein, S.A. & Baldwin, J.N. Loss of the penicillinase plasmid after treatment of Staphylococcus aureus with sodium dodecyl sulfate. J. Bacteriol. 109, 262\u2013265 (1972).","journal-title":"J. Bacteriol."},{"key":"BFnchembio1911_CR46","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1128\/AAC.37.5.1144","volume":"37","author":"CJ Hackbarth","year":"1993","unstructured":"Hackbarth, C.J. & Chambers, H.F. blaI and blaR1 regulate \u03b2-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 37, 1144\u20131149 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR47","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1172\/JCI18535","volume":"111","author":"FD Lowy","year":"2003","unstructured":"Lowy, F.D. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 111, 1265\u20131273 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnchembio1911_CR48","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1021\/bi500074w","volume":"53","author":"B Bl\u00e1zquez","year":"2014","unstructured":"Bl\u00e1zquez, B. et al. Regulation of the expression of the \u03b2-lactam antibiotic-resistance determinants in methicillin-resistant Staphylococcus aureus (MRSA). Biochemistry 53, 1548\u20131550 (2014).","journal-title":"Biochemistry"},{"issue":"suppl. 2","key":"BFnchembio1911_CR49","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.1093\/clinids\/24.Supplement_2.S266","volume":"24","author":"WA Craig","year":"1997","unstructured":"Craig, W.A. The pharmacology of meropenem, a new carbapenem antibiotic. Clin. Infect. Dis. 24 (suppl. 2) S266\u2013S275 (1997).","journal-title":"Clin. Infect. Dis."},{"key":"BFnchembio1911_CR50","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1128\/AAC.00752-06","volume":"51","author":"CA DeRyke","year":"2007","unstructured":"DeRyke, C.A., Banevicius, M.A., Fan, H.W. & Nicolau, D.P. Bactericidal activities of meropenem and ertapenem against extended-spectrum-\u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model. Antimicrob. Agents Chemother. 51, 1481\u20131486 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnchembio1911_CR51","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ja.2007.45","volume":"60","author":"Y Cai","year":"2007","unstructured":"Cai, Y., Wang, R., Pei, F. & Liang, B.-b. Antibacterial activity of allicin alone and in combination with \u03b2-lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J. Antibiot. (Tokyo) 60, 335\u2013338 (2007).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFnchembio1911_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","volume":"137","author":"MC Berenbaum","year":"1978","unstructured":"Berenbaum, M.C. A method for testing for synergy with any number of agents. J. Infect. Dis. 137, 122\u2013130 (1978).","journal-title":"J. Infect. Dis."},{"key":"BFnchembio1911_CR53","unstructured":"NCCLS. Methods for determining bactericidal activity of antimicrobial agents: approved guideline. (NCCLS document no. M26-A) (NCCLS, Wayne, Pennsylvania, 1999)."},{"key":"BFnchembio1911_CR54","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"BFnchembio1911_CR55","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1128\/AAC.40.6.1508","volume":"40","author":"CW Ford","year":"1996","unstructured":"Ford, C.W. et al. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob. Agents Chemother. 40, 1508\u20131513 (1996).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1911.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1911","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.1911.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T16:41:37Z","timestamp":1748623297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFnchembio1911"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.1911","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]},"assertion":[{"value":"11 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.R.G., M.W.P., S.M., M.C. and G.D. have submitted provisional US patent application no. 62\/190,588 based on the antibiotic combination results described in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}